Description
Recombinant monoclonal antibody to CD44. Manufactured using AbAbТs Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 156-3C11. This is a reformatted human IgG1 Fc SilentЩ antibody, based on the original human IgG2a format, created for improved compatibility with existing reagents, assays and techniques.
Target
CD44
Target Alias Names
CDw44, PGP-1, PGP-I, ECMR-III, Epican, HUTCH-I, Hermes antigen, Hyaluronate receptor, Phagocytic glycoprotein I, Phagocytic glycoprotein 1, Extracellular matrix receptor III, GP90 lymphocyte homing/adhesion receptor
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression